Assessing different measures of population-level vaccine protection using a case-control study

Area of Science:

• Epidemiology
• Vaccinology
• Biostatistics

Background:

• The utility of case-control studies for evaluating population-level vaccine protection in individually randomized trials (IRTs) has not been previously examined.
• Assessing vaccine effectiveness at a population level is crucial for public health decision-making.

Purpose of the Study:

• To compare the effectiveness of case-control analyses with traditional cohort analyses in assessing vaccine protection using data from a randomized, placebo-controlled cholera vaccine trial.
• To determine if case-control methods can accurately estimate both direct and indirect vaccine effects.

Main Methods:

• Utilized data from a 3-year randomized, placebo-controlled cholera vaccine trial.
• Employed case-control and cohort analyses, comparing results for direct and indirect vaccine protection.
• Integrated Geographic Information System (GIS) to calculate vaccine coverage in surrounding clusters for each case and control.

Main Results:

• Case-control analysis estimated 84% direct vaccine protection (95% CI: 60-94%), comparable to cohort analysis (78%).
• Estimated indirect protection was higher with case-control analysis (76%, 95% CI: 47-89%) versus cohort analysis (52%, 95% CI: 10-74%).
• Overall vaccine effectiveness estimates were similar between case-control and cohort approaches.

Conclusions:

• Case-control analyses are a viable and effective method for evaluating direct vaccine protection in IRTs.
• Case-control studies can also successfully assess population-level (indirect) vaccine protection within IRTs.
• Findings support the use of case-control designs to complement traditional analyses in vaccine trials.